<DOC>
	<DOCNO>NCT00429091</DOCNO>
	<brief_summary>A Dose-Ranging Study Efficacy ABT-894 Adults Attention-Deficit/Hyperactivity Disorder ( ADHD )</brief_summary>
	<brief_title>A Dose-Ranging Study Efficacy ABT-894 Adults With Attention-Deficit/Hyperactivity Disorder ( ADHD )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Meet criterion attentiondeficit/hyperactivity disorder Have voluntarily sign inform form Are 18 60 year age Will use contraceptive method study Women must pregnant breastfeeding Must generally good health Are fluent English They current past diagnosis schizoaffective disorder , schizophrenia , obsessivecompulsive disorder , druginduced psychosis , bipolar disorder , psychotic disorder mental retardation They current diagnosis major depressive episode , generalize anxiety disorder ( GAD ) , posttraumatic stress disorder ( PTSD ) clinically significant sleep disorder require treatment They require ongoing treatment expect treatment psychotropic medication , include anxiolytic , antipsychotic , anticonvulsant , antidepressant , mood stabilizer , nicotine replacement therapy varenicline They require ongoing treatment expect treatment Coumadin They fail respond two adequate trial FDAapproved ADHD medication They take atomoxetine last 3 month They violent , homicidal suicidal ideation They significant history medical diagnosis , seizure disorder , Tourette 's syndrome , traumatic brain injury , central nervous system ( CNS ) disease , exclude ADHD They urine drug screen positive alcohol drug abuse They history substance alcohol disorder last 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2010</verification_date>
</DOC>